Emil Bulatov

1.6k total citations
55 papers, 1.2k citations indexed

About

Emil Bulatov is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Emil Bulatov has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 31 papers in Oncology and 13 papers in Genetics. Recurrent topics in Emil Bulatov's work include CAR-T cell therapy research (20 papers), Virus-based gene therapy research (11 papers) and Ubiquitin and proteasome pathways (10 papers). Emil Bulatov is often cited by papers focused on CAR-T cell therapy research (20 papers), Virus-based gene therapy research (11 papers) and Ubiquitin and proteasome pathways (10 papers). Emil Bulatov collaborates with scholars based in Russia, China and United Kingdom. Emil Bulatov's co-authors include Alessio Ciulli, Albert A. Rizvanov, Ekaterina Zmievskaya, Aygul Valiullina, Alexey Petukhov, Irina Ganeeva, Regina Miftakhova, Aleksei Titov, Almaz A. Zagidullin and Nickolai A. Barlev and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Emil Bulatov

54 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emil Bulatov Russia 22 726 610 250 140 133 55 1.2k
Pavel Klener Czechia 25 631 0.9× 638 1.0× 266 1.1× 83 0.6× 105 0.8× 121 1.6k
Camilla L. Christensen Denmark 19 795 1.1× 600 1.0× 158 0.6× 119 0.8× 104 0.8× 34 1.4k
Shabnum Patel United States 14 455 0.6× 273 0.4× 249 1.0× 120 0.9× 227 1.7× 27 1.1k
Torbjörn Gräslund Sweden 24 1.1k 1.5× 450 0.7× 189 0.8× 68 0.5× 92 0.7× 67 1.7k
Jamie B. Spangler United States 20 605 0.8× 617 1.0× 785 3.1× 98 0.7× 147 1.1× 63 1.6k
Xin‐an Lu China 21 776 1.1× 613 1.0× 158 0.6× 160 1.1× 150 1.1× 45 1.4k
Constantina Christodoulou United States 12 894 1.2× 211 0.3× 156 0.6× 133 0.9× 126 0.9× 15 1.8k
Amer Najjar United States 18 517 0.7× 1000 1.6× 413 1.7× 276 2.0× 377 2.8× 29 1.6k
Zhiwu Jiang China 16 356 0.5× 328 0.5× 225 0.9× 83 0.6× 95 0.7× 31 782
Isolda Casanova Spain 27 1.0k 1.4× 709 1.2× 418 1.7× 86 0.6× 167 1.3× 67 1.9k

Countries citing papers authored by Emil Bulatov

Since Specialization
Citations

This map shows the geographic impact of Emil Bulatov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emil Bulatov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emil Bulatov more than expected).

Fields of papers citing papers by Emil Bulatov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emil Bulatov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emil Bulatov. The network helps show where Emil Bulatov may publish in the future.

Co-authorship network of co-authors of Emil Bulatov

This figure shows the co-authorship network connecting the top 25 collaborators of Emil Bulatov. A scholar is included among the top collaborators of Emil Bulatov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emil Bulatov. Emil Bulatov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zmievskaya, Ekaterina, Irina Ganeeva, Yuriy Davidyuk, et al.. (2024). Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies. Antibodies. 13(1). 10–10. 20 indexed citations
3.
Bulatov, Emil, et al.. (2024). Impact of TP53 mutations on the efficacy of CAR-T cell therapy in cancer. SHILAP Revista de lepidopterología. 837–852. 2 indexed citations
4.
Valiullina, Aygul, et al.. (2024). Breaking the shield of solid tumors: a combined approach for enhanced efficacy of CAR-T cells. Cancer Immunology Immunotherapy. 74(1). 3–3. 4 indexed citations
5.
Zmievskaya, Ekaterina, Irina Ganeeva, М. П. Кутырева, et al.. (2024). Artificial Extracellular Vesicles Generated from T Cells Using Different Induction Techniques. Biomedicines. 12(4). 919–919. 6 indexed citations
6.
Yakimova, Luidmila S., Olga A. Mostovaya, Igor A. Sedov, et al.. (2023). Decasubstituted Pillar[5]arene Derivatives Containing L-Tryptophan and L-Phenylalanine Residues: Non-Covalent Binding and Release of Fluorescein from Nanoparticles. International Journal of Molecular Sciences. 24(9). 7700–7700. 4 indexed citations
7.
Dong, Yansong, Yalan Tu, Ye Liu, et al.. (2023). Perivascular nanocarrier aggregation as a drug reservoir augments tumor drug delivery and treatment efficacy. Nano Today. 53. 102004–102004. 3 indexed citations
8.
9.
Bulatov, Emil, et al.. (2023). Adipose-Derived Mesenchymal Stem Cell (MSC) Immortalization by Modulation of hTERT and TP53 Expression Levels. Journal of Personalized Medicine. 13(11). 1621–1621. 6 indexed citations
10.
Mironova, Diana, Elza D. Sultanova, Vladimir G. Evtugyn, et al.. (2023). Aggregation, Cytotoxicity and DNA Binding in a Series of Calix[4]arene Amphiphile Containing Aminotriazole Groups. Pharmaceuticals. 16(5). 699–699. 5 indexed citations
11.
Bulatov, Emil, et al.. (2022). Experimental Study of the In Vitro and In Vivo Functional Activity of NKG2D Chimeric Antigen Receptor. SHILAP Revista de lepidopterología. 15(4). 327–339. 1 indexed citations
12.
Dorogan, Igor V., Emil Bulatov, Ilya G. Serebriiskii, et al.. (2021). Design, synthesis and biological evaluation of 2-quinolyl-1,3-tropolone derivatives as new anti-cancer agents. RSC Advances. 11(8). 4555–4571. 10 indexed citations
13.
Zmievskaya, Ekaterina, et al.. (2021). Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies. Frontiers in Immunology. 12. 707734–707734. 36 indexed citations
14.
Zaikova, Ekaterina, А. С. Головкин, Emil Bulatov, et al.. (2020). Granulocyte-Macrophage Colony-Stimulating Factor and CAR-T Technology for Solid Tumors in Experiment. SHILAP Revista de lepidopterología. 13(2). 115–122. 2 indexed citations
15.
Zagidullin, Almaz A., et al.. (2020). Novel approaches for the rational design of PROTAC linkers. SHILAP Revista de lepidopterología. 1(5). 381–390. 43 indexed citations
16.
Zmievskaya, Ekaterina, et al.. (2020). Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy. Frontiers in Oncology. 10. 1460–1460. 30 indexed citations
17.
Valiullina, Aygul, Marina Gomzikova, Ekaterina Garanina, et al.. (2017). Small Molecule p53-MDM2 Inhibitors As Potential Regulators of p53-Dependent Genes Expression in Multiple Sclerosis. Blood. 130. 4820–4820. 1 indexed citations
18.
19.
Bulatov, Emil & Alessio Ciulli. (2015). Targeting Cullin–RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation. Biochemical Journal. 467(3). 365–386. 185 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pavel Klener Breakdown of academic impact, for papers by Camilla L. Christensen Breakdown of academic impact, for papers by Shabnum Patel Breakdown of academic impact, for papers by Torbjörn Gräslund Breakdown of academic impact, for papers by Jamie B. Spangler Breakdown of academic impact, for papers by Xin‐an Lu Breakdown of academic impact, for papers by Constantina Christodoulou Breakdown of academic impact, for papers by Amer Najjar Breakdown of academic impact, for papers by Zhiwu Jiang Breakdown of academic impact, for papers by Isolda Casanova
Rankless by CCL
2026